The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...

A 36-year-old woman from Karaikal, who had been suffering from lower back pain for three years along with constant pain in her right leg, has regained mobility following a spine surgery at Karaikal ...

Researchers found that epidural steroid injections may modestly reduce pain and disability in patients with a pinched nerve ...

Question: I have recently been diagnosed with sciatica and I am finding it difficult to do any exercise. My usual form of ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with acute pain. The FDA has approved the non-opioid, highly selective ...

Vertex is studying suzetrigine in sciatica; in a phase II trial, the drug showed a statistically significant change in lumbosacral radiculopathy pain from baseline, similar to the reduction in the ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).